Midterm Outcomes of Castor Stent Graft in Treatment of Type B Aortic Dissection Involving Left Subclavian Artery: A Retrospective Single‐Center Study
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Mixia Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The Second Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Aortic Dissection, Endovascular Procedures, Blood Vessel Prosthesis Implantation, Stents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: This work was supported by the project of the Jilin Provincial Science and Technology Project, China (Grant 20220508070)..
Abstract (Originalsprache)
Objective
For type B aortic dissection (TBAD) involving the left subclavian artery (LSA), to secure sufficient proximal landing zones, the LSA can be intentionally covered during thoracic endovascular aortic repair (TEVAR). This study aimed to evaluate the midterm clinical outcomes of endovascular treatment for TBAD involving the LSA using the Castor single‐branched stent graft.
Aims
The aim of this study was to evaluate the midterm efficacy and safety of Cator stent graft in the treatment of type B aortic dissection involving left subclavian artery.
Methods
From May 2018 to December 2022, 150 patients with TBAD involving the LSA were treated with the Castor single‐branched stent graft (Micropart Corp, Shanghai, China). The data collected included technical success, incidences of Type I endoleak, retrograde type A dissection (RTAD), stroke, LSA patency, as well as follow‐up mortality and morbidity, and reinterventions.
Results
The technical success rate was 97.3% (146/150). One patient experienced intraoperative RTAD, two patients had a small type I endoleak, and one patient suffered a stroke. Moreover, one patient developed RTAD on the third day after TEVAR. No in‐hospital aorta‐related mortality, paraplegia, or branch occlusion. During follow‐up, one case (0.7%) of small endoleak, one case (0.7%) of branch occlusion, and two deaths were documented. Complete thrombosis of the false lumens was observed in 140 cases (99.3%). The true lumen diameter at the level of the aortic isthmus and pulmonary artery bifurcation increased significantly (13.3 ± 7.5 vs. 4.2 ± 2.1; 19.8 ± 5.7 vs. 5.4 ± 4.8, p < 0.01), and the ratio of the real lumen increased significantly (0.6 ± 0.2 vs. 0.9 ± 0.1; 0.4 ± 0.1 vs. 0.8 ± 0.1, p < 0.01). The median follow‐up time was 36.0 months (IQR, 11.8 months) (range: 6−72 months).
Conclusion
The Castor single‐branched stent graft showed favorable midterm outcomes in the treatment of TBAD involving the LSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The Second Hospital of Jilin University, Changchun, China.
ORCID-Profile: Mixia Li
Förderung
- This work was supported by the project of the Jilin Provincial Science and Technology Project, China (Grant 20220508070).
Zitieren
APA
Li, M., Yuan, L., Wang, D., Wang, Y., Piao, H., & Liu, K. (2025). Midterm Outcomes of Castor Stent Graft in Treatment of Type B Aortic Dissection Involving Left Subclavian Artery: A Retrospective Single‐Center Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31643
Vancouver
Li M, Yuan L, Wang D, Wang Y, Piao H, Liu K. Midterm Outcomes of Castor Stent Graft in Treatment of Type B Aortic Dissection Involving Left Subclavian Artery: A Retrospective Single‐Center Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31643
BibTeX
@article{Li2025,
author = {Li, Mixia and Yuan, Lei and Wang, Duo and Wang, Yong and Piao, Hulin and Liu, Kexiang},
title = {Midterm Outcomes of Castor Stent Graft in Treatment of Type B Aortic Dissection Involving Left Subclavian Artery: A Retrospective Single‐Center Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31643}
}
EUVIMED